Article
New Orleans - A small, hand-held, nonpulsatile, optical diffusion oximeter (FireFly Tissue Oximeter, Spectros) shows promise as a tool for assessing flap viability and, thereby, enabling intraoperative modifications, postoperative revisions, and ultimately outcomes of flap reconstruction surgery, according to the results of a pilot study conducted by researchers in the department of dermatology, Stanford University, Stanford, Calif.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.